Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Liberating health data for clinical research applications.

Nadler JJ, Downing GJ.

Sci Transl Med. 2010 Feb 10;2(18):18cm6. doi: 10.1126/scitranslmed.3000764.

PMID:
20371480
2.

Enhancing the quality and efficiency of newborn screening programs through the use of health information technology.

Downing GJ, Zuckerman AE, Coon C, Lloyd-Puryear MA.

Semin Perinatol. 2010 Apr;34(2):156-62. doi: 10.1053/j.semperi.2009.12.005.

PMID:
20207265
3.

Policy perspectives on the emerging pathways of personalized medicine.

Downing GJ.

Dialogues Clin Neurosci. 2009;11(4):377-87. Review.

4.

Key aspects of health system change on the path to personalized medicine.

Downing GJ.

Transl Res. 2009 Dec;154(6):272-6. doi: 10.1016/j.trsl.2009.09.003. Epub 2009 Oct 6.

PMID:
19931192
5.

Information management to enable personalized medicine: stakeholder roles in building clinical decision support.

Downing GJ, Boyle SN, Brinner KM, Osheroff JA.

BMC Med Inform Decis Mak. 2009 Oct 8;9:44. doi: 10.1186/1472-6947-9-44.

6.

The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop.

Khoury MJ, McBride CM, Schully SD, Ioannidis JP, Feero WG, Janssens AC, Gwinn M, Simons-Morton DG, Bernhardt JM, Cargill M, Chanock SJ, Church GM, Coates RJ, Collins FS, Croyle RT, Davis BR, Downing GJ, Duross A, Friedman S, Gail MH, Ginsburg GS, Green RC, Greene MH, Greenland P, Gulcher JR, Hsu A, Hudson KL, Kardia SL, Kimmel PL, Lauer MS, Miller AM, Offit K, Ransohoff DF, Roberts JS, Rasooly RS, Stefansson K, Terry SF, Teutsch SM, Trepanier A, Wanke KL, Witte JS, Xu J; Centers for Disease Control and Prevention.

Genet Med. 2009 Aug;11(8):559-67. doi: 10.1097/GIM.0b013e3181b13a6c.

7.

Advancing patient-centered pediatric care through health information exchange: update from the American Health Information Community Personalized Health Care Workgroup.

Brinner KA, Downing GJ; American Health Information Community Personalized Health Care Workgroup.

Pediatrics. 2009 Jan;123 Suppl 2:S122-4. doi: 10.1542/peds.2008-1755N.

PMID:
19088228
8.

Toward a future of personalized cancer care.

Leavitt MO, Downing GJ.

Cancer. 2008 Oct 1;113(7 Suppl):1724-7. doi: 10.1002/cncr.23641. No abstract available.

9.

A reagent resource to identify proteins and peptides of interest for the cancer community: a workshop report.

Haab BB, Paulovich AG, Anderson NL, Clark AM, Downing GJ, Hermjakob H, Labaer J, Uhlen M.

Mol Cell Proteomics. 2006 Oct;5(10):1996-2007. Epub 2006 Jul 24.

10.

A short primer on stem cells.

Zerhouni EA, Battey JF Jr, Downing GJ.

Md Med. 2005 Winter;6(1):14-7. No abstract available.

PMID:
15869101
11.
12.

Enhancing pathways to therapeutic development with clinical biomarkers.

Downing GJ.

Am J Geriatr Psychiatry. 2002 Nov-Dec;10(6):646-8. No abstract available.

PMID:
12427572
13.

Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.

De Gruttola VG, Clax P, DeMets DL, Downing GJ, Ellenberg SS, Friedman L, Gail MH, Prentice R, Wittes J, Zeger SL.

Control Clin Trials. 2001 Oct;22(5):485-502.

PMID:
11578783
14.

Localization of two distinct type III phosphatidylinositol 4-kinase enzyme mRNAs in the rat.

Zólyomi A, Zhao X, Downing GJ, Balla T.

Am J Physiol Cell Physiol. 2000 May;278(5):C914-20.

15.

Isolation and molecular cloning of wortmannin-sensitive bovine type III phosphatidylinositol 4-kinases.

Balla T, Downing GJ, Jaffe H, Kim S, Zólyomi A, Catt KJ.

J Biol Chem. 1997 Jul 18;272(29):18358-66.

16.
17.

Modification of native collagen reduces antigenicity but preserves cell compatibility.

Hardin-Young J, Carr RM, Downing GJ, Condon KD, Termin PL.

Biotechnol Bioeng. 1996 Mar 20;49(6):675-82.

PMID:
18626863
18.

Characterization of a soluble adrenal phosphatidylinositol 4-kinase reveals wortmannin sensitivity of type III phosphatidylinositol kinases.

Downing GJ, Kim S, Nakanishi S, Catt KJ, Balla T.

Biochemistry. 1996 Mar 19;35(11):3587-94.

PMID:
8639510
19.

Human chorionic gonadotropin stimulates placental prorenin secretion: evidence for autocrine/paracrine regulation.

Downing GJ, Maulik D, Poisner AM.

J Clin Endocrinol Metab. 1996 Mar;81(3):1027-30.

PMID:
8772570
20.

Stimulation of placental prorenin secretion by selective inhibition of cyclic nucleotide phosphodiesterases.

Downing GJ, Poisner AM.

Biochem Pharmacol. 1995 May 26;49(11):1675-82.

PMID:
7540392
21.
22.

First-trimester villous placenta has high prorenin and active renin concentrations.

Downing GJ, Poisner AM, Barnea ER.

Am J Obstet Gynecol. 1995 Mar;172(3):864-7.

PMID:
7892876
23.

cAPK mediates placental renin secretion stimulated by beta-adrenoceptor activation.

Downing GJ, Poisner AM.

Am J Physiol. 1994 Dec;267(6 Pt 1):E954-60.

PMID:
7810640
24.

Prorenin secretion from villous placenta: regulation by cyclic AMP and angiotensin.

Poisner AM, Downing GJ, Poisner R.

Placenta. 1994 Jul;15(5):487-99.

PMID:
7997449
25.
26.

Phosphodiesterase inhibitors have differential effects on placental versus decidual prorenin release.

Poisner AM, Downing GJ, Poisner R.

Proc West Pharmacol Soc. 1994;37:87-8. No abstract available.

PMID:
7984682
27.
28.

Acquired subglottic cysts in the low-birth-weight infant. Characteristics, treatment, and outcome.

Downing GJ, Hayen LK, Kilbride HW.

Am J Dis Child. 1993 Sep;147(9):971-4.

PMID:
8362815
29.

Echocardiographically guided balloon atrial septostomy during extracorporeal membrane oxygenation (ECMO).

O'Connor TA, Downing GJ, Ewing LL, Gowdamarajan R.

Pediatr Cardiol. 1993 Jul;14(3):167-8.

PMID:
8415220
30.

In vivo correlation of Doppler waveform analysis with arterial input impedance parameters.

Downing GJ, Maulik D, Phillips C, Kadado TR.

Ultrasound Med Biol. 1993;19(7):549-59.

PMID:
8310551
31.

Antepartum fetomaternal hemorrhage. Report of a case with the use of cordocentesis in diagnosis and management.

Downing GJ, Vandenboom E, Thorp JA.

J Reprod Med. 1992 Jun;37(6):566-8.

PMID:
1619613
32.

Kidney function in very low birth weight infants with furosemide-related renal calcifications at ages 1 to 2 years.

Downing GJ, Egelhoff JC, Daily DK, Thomas MK, Alon U.

J Pediatr. 1992 Apr;120(4 Pt 1):599-604.

PMID:
1552401
33.

Tracheal agenesis with diaphragmatic hernia.

Downing GJ.

Am J Med Genet. 1992 Jan 1;42(1):85-7.

PMID:
1308369
34.

Comparison of the pulsatility index and input impedance parameters in a model of altered hemodynamics.

Downing GJ, Yarlagadda AP, Maulik D.

J Ultrasound Med. 1991 Jun;10(6):317-21.

PMID:
1895373
35.
36.

Characteristics of perinatal cocaine-exposed infants with necrotizing enterocolitis.

Downing GJ, Horner SR, Kilbride HW.

Am J Dis Child. 1991 Jan;145(1):26-7. No abstract available.

PMID:
1985422
37.

Effects of acute hypoxemia on umbilical arterial Doppler indices in a fetal ovine model.

Downing GJ, Yarlagadda P, Maulik D.

Early Hum Dev. 1991 Jan-Feb;25(1):1-10.

PMID:
1905223
38.

Furosemide-related renal calcifications in the premature infant. A longitudinal ultrasonographic study.

Downing GJ, Egelhoff JC, Daily DK, Alon U.

Pediatr Radiol. 1991;21(8):563-5.

PMID:
1815176
39.

Picture of the month. Nasopharyngeal teratomas.

Downing GJ, Kilbride HW, Freeman JC, Feingold M.

Am J Dis Child. 1990 Jul;144(7):795-6. No abstract available.

PMID:
2356799
41.

Group C beta-hemolytic streptococcal endocarditis.

Downing GJ, Spirazza C.

Pediatr Infect Dis. 1986 Nov-Dec;5(6):703-4. No abstract available.

PMID:
3797302

Supplemental Content

Loading ...
Support Center